Latest Breaking News On - Exhibitor spotlight - Page 1 : vimarsana.com

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Strong commercial performance of IBSRELA continues, ending FY 2023 with $80.1 million in net product sales revenue; 2024 net product sales revenue currently expected to be between $140.0 to $150.0

United statesCaitlin lowieArnold silvaMike raabPhilip schoenfeldDavid spiegelFosun pharmaCompany annual report on formInvestment corpBoise kidney hypertension instituteJapanese ministry of healthAmerican society of nephrology kidney weekExchange commissionDrug administrationExchange commission onJohnd dingell va medical center

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDerek forfangDavid spiegelTenapanor monotherapyLaura williamsArnold silvaDrug administration onAmerican society of nephrologyBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican societyKidney weekExhibitor spotlightDrug administration

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesArnold silvaTenapanor monotherapyFosun pharmaDerek forfangDavid spiegelLaura williamsCaitlin lowieKimia keshtbodBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican society of nephrologyDrug administration onAmerican society

Ardelyx Shares Positive Data from Studies of XPHOZAH (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

03.11.2023 - WALTHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) - Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical . Seite 1

United statesDerek forfangArdelyx patient advisory councilDrug administration onAmerican society of nephrologyArdelyx incAmerican societyKidney weekExhibitor spotlightDrug administrationArdelyx chartRdelyx kursRdelyx aktie

3 Day United States Higher Education Leadership Conference:

Dublin, March 31, 2023 (GLOBE NEWSWIRE) The "Leadership in Higher Education Conference" conference has been added to ResearchAndMarkets.com's.

United statesAdvisory board panelProgram or project directorsDivision headsHigher educationHigher education conferenceShould attendGreater leadershipExhibitor spotlightAdvisory boardResearch and marketsHigher and further education